Medicus Pharma has received authorisation from the UAE Department of [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

The US Food and Drug Administration (FDA) has approved Meitheal [...]

Verdiva Bio has dosed the first patient in a Phase [...]

AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

ProMIS Neurosciences has reported six-month interim safety and biomarker data [...]

PolyPid’s D-PLEX100 has been granted FDA Priority Review following acceptance [...]

HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]

Amorphical has completed patient enrolment in a Phase 2 trial [...]